Clinical Trial Detail

NCT ID NCT03893487
Title Fimepinostat in Treating Brain Tumors in Children and Young Adults (PNOC016)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sabine Mueller, MD, PhD
Indications

malignant glioma

glioblastoma multiforme

medulloblastoma

grade III astrocytoma

Therapies

CUDC-907

Age Groups: adult child

No variant requirements are available.